查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1803032

全球 PTSD VR 治疗市场预测（至 2032 年）：按类型、组件、模式、应用、最终用户和地区进行分析

PTSD VR Therapy Market Forecasts to 2032 - Global Analysis By Type, Component, Modality, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球 PTSD VR 治疗市场规模预计在 2025 年达到 17.4 亿美元，到 2032 年将达到 54.9 亿美元，预测期内的复合年增长率为 17.8%。

PTSD VR 疗法是一种技术主导的治疗方法利用身临其境型虚拟实境环境，帮助患者在可控的治疗环境中面对和处理创伤经历。透过模拟针对患者创伤情况量身定制的真实场景，该疗法可以促进暴露疗法、情绪调节和认知重建。这种方法可以提高患者的参与度，减少迴避行为，并支持渐进式脱敏。临床医生会监测患者的反应并调整刺激以优化治疗效果，这使得 VR 疗法成为创伤后压力症候群管理中个人化、循证护理的有前景的工具。

根据《国际环境研究与公共健康杂誌》的报道，基于虚拟实境的分级暴露疗法（VR-GET）在减轻创伤后压力症候群症状方面表现出显着的有效性。

VR硬体的快速发展和临床有效性的验证

临床研究表明，在VR环境中进行的暴露疗法可以显着改善创伤后压力症候群（PTSD）症状，从而验证了其治疗潜力。与生物感测器和AI主导的反馈迴路的集成，进一步实现了治疗的检验。随着医疗服务提供者寻求可扩展的非侵入式解决方案，VR疗法作为传统疗法的可行替代方案正日益受到关注。这些技术创新正在增强治疗的真实感和患者参与度，使基于VR的干预措施更加有效，并推动市场成长。

针对不同族群的证据有限

大多数临床试验都集中在退伍军人或特定的创伤族群中，因此在儿童、老年人和文化背景多元的人群中，对其疗效的理解仍有空白。缺乏全面的数据限制了VR技术的广泛应用，并引发了对其普遍适用性的担忧。此外，语言障碍和创伤应变中的文化差异可能会影响标准化VR模组的有效性。如果没有涵盖全球人群的、经过同行评审的严谨研究，监管部门的核准和保险报销仍然有限。

扩展到更广泛的心理健康

除了创伤后压力症候群 (PTSD)，VR 疗法已展现出治疗多种心理健康问题的潜力，包括焦虑症、恐惧症、忧郁症和药物滥用。 VR 平台的模组化特性使其能够快速调整治疗内容，以满足各种心理需求。随着全球心理健康意识的增强，对便利、技术支援的介入措施的需求也日益增长。医疗保健机构正在探索将 VR 用于团体治疗、正念训练和认知康復，将其定位为下一代行为疗法的基石，并开闢新的收益来源。

与现有疗法的竞争

VR疗法的新颖性必然会与现有治疗方法竞争，例如药物治疗、认知行为疗法 (CBT) 和眼动减敏与再处理 (EMDR)。这些方法已经经过数十年的临床检验，并被医生广泛熟悉，使其成为许多医疗服务提供者的预设选择。此外，报销框架和临床指南通常更倾向于传统疗法，这限制了VR的市场渗透。临床医师对VR解决方案的长期疗效和成本效益的怀疑可能会进一步阻碍其应用。

COVID-19的影响：

疫情加速了人们对远距和数位化心理健康解决方案的兴趣，包括利用虚拟实境技术治疗创伤后压力症候群 (PTSD)。由于封锁和保持社交距离措施扰乱了面对面的咨询服务，医疗服务提供者寻求身临其境型技术来确保护理的连续性。 VR 平台使患者能够在家中接受暴露疗法，减少了就诊障碍并提高了治疗依从性。然而，供应链中断影响了硬体供应，经济不确定性限制了机构对新技术的投资。

认知行为疗法预计将成为预测期内最大的市场

认知行为疗法 (CBT) 领域预计将在预测期内占据最大市场占有率，这得益于其结构化、循证的方法以及与 VR 产品的高度契合。 CBT 模组可以有效地转化为身临其境型场景，使患者能够在受控环境中面对并重塑创伤记忆。 CBT 因其对各种创伤类型的适应性以及与数位平台的兼容性而受到临床医生的青睐。

预计创伤后压力症候群 (PTSD) 领域在预测期内将以最高复合年增长率成长

由于人们对创伤相关疾病的认识和诊断不断提高，因此预计创伤后压力症候群 (PTSD) 领域将在预测期内实现最高成长率。 PTSD 在一般大众、初期应变人员和医疗保健专业人员中的盛行率正在上升，目标人口不断扩大。 VR 疗法尤其受到年轻人的青睐，因为它提供了一种非侵入性且不受歧视的传统咨询替代方案。针对创伤的 VR 模组的持续研究以及机构对倡议日益增长的支持，正在推动市场扩张。

比最大的地区

预计亚太地区将在预测期内占据最大的市场占有率，这得益于心理健康意识的不断增强以及数位医疗基础设施的不断普及。中国、日本和韩国等国家正大力投资VR技术，并将其融入其公共卫生体系。政府为促进心理健康和创伤復原而推出的支持倡议，也为市场成长创造了有利条件。

复合年增长率最高的地区：

预计北美将在预测期内呈现最高的复合年增长率，这得益于其强大的医疗基础设施、新兴技术的早期应用以及VR治疗新兴企业的强劲发展。该地区受益于优惠的报销政策、积极的研究资金以及创伤后压力症候群（PTSD）的高发生率，尤其是在退伍军人群体中。科技公司与学术机构之间的合作正在激发创新，同时监管机构也越来越认可VR作为合法的治疗工具。

提供免费客製化：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究资讯来源
    • 初级研究资讯来源
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球 PTSD VR 治疗市场（按类型）

  • 暴露疗法
  • 认知行为疗法
  • 眼动脱敏与再加工
  • 生物回馈疗法增强VR疗法
  • 联合/混合治疗模型
  • 其他类型

6. 全球 PTSD VR 治疗市场（按组成部分）

  • 硬体
    • 头戴式显示器（HMD）
    • 控制器和追踪系统
    • 生理感测器
    • 触觉和周边设备
  • 软体
    • 模拟内容和场景库
    • 临床管理和分析软体
  • 服务
    • 软体客製化与整合服务
    • 临床实施与治疗师培训
    • 维护和支援
  • 其他组件

7. 全球 PTSD VR 治疗市场（按模式）

  • 身临其境型虚拟实境
  • 半身临其境型
  • 非身临其境型

8. 全球 PTSD VR 治疗市场（按应用）

  • 忧郁症
  • 焦虑症
  • 创伤后压力症候群（PTSD）
  • 疼痛管理
  • 成瘾管理
  • 其他用途

9. 全球 PTSD VR 治疗市场（按最终用户）

  • 治疗诊所和復健中心
  • 军事/国防
  • 医院和诊所
  • 研究和学术机构
  • 居家照护环境
  • 其他最终用户

第十章 全球 PTSD VR 治疗市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • XRHealth
  • AppliedVR
  • Limbix
  • Psious
  • MyndVR
  • KindVR
  • Corpus VR
  • Cognihab
  • RelieVRx
  • Virtually Better
  • Neuro Rehab VR
  • PsyTech VR
  • oVRcome
  • Floreo
  • BehaVR
  • Oxford VR
  • Enosis Therapeutics
Product Code: SMRC30558

According to Stratistics MRC, the Global PTSD VR Therapy Market is accounted for $1.74 billion in 2025 and is expected to reach $5.49 billion by 2032 growing at a CAGR of 17.8% during the forecast period. PTSD VR therapy is a technology-driven treatment that uses immersive virtual reality environments to help individuals confront and process traumatic experiences in a controlled, therapeutic setting. By simulating realistic scenarios tailored to the patient's trauma, it facilitates exposure therapy, emotional regulation, and cognitive restructuring. This method enhances engagement, reduces avoidance behaviors, and supports gradual desensitization. Clinicians monitor responses and adjust stimuli to optimize outcomes, making VR therapy a promising tool for personalized, evidence-based care in post-traumatic stress disorder management.

According to International Journal of Environmental Research and Public Health, Virtual Reality-Based Graded Exposure Therapy (VR-GET) demonstrated a significantly larger effect size for reducing PTSD symptoms.

Market Dynamics:

Driver:

Rapid evolution of VR hardware & proven clinical efficacy

Clinical studies have demonstrated measurable improvements in PTSD symptoms through exposure therapy conducted in VR environments, validating its therapeutic potential. Integration with biometric sensors and AI-driven feedback loops is further elevating treatment personalization. As healthcare providers seek scalable and non-invasive solutions, VR therapy is gaining traction as a viable alternative to traditional methods. These innovations are enhancing therapeutic realism and patient engagement, making VR-based interventions more effective boosting the market growth.

Restraint:

Limited evidence for diverse populations

Most trials have focused on military veterans or specific trauma cohorts, leaving gaps in understanding efficacy among children, elderly patients, and culturally diverse populations. This lack of inclusive data limits broader adoption and raises concerns about generalizability. Additionally, language barriers and cultural nuances in trauma response may affect the effectiveness of standardized VR modules. Without robust, peer-reviewed studies encompassing global populations, regulatory approvals and insurance reimbursements remain constrained.

Opportunity:

Expansion into broader mental health

Beyond PTSD, VR therapy is showing potential in addressing a wider spectrum of mental health conditions such as anxiety disorders, phobias, depression, and substance abuse. The modular nature of VR platforms allows for rapid adaptation of therapeutic content to suit different psychological needs. As mental health awareness grows globally, demand for accessible, tech-enabled interventions is surging. Institutions are exploring VR for group therapy, mindfulness training, and cognitive rehabilitation, opening new revenue streams positioning VR as a cornerstone of next-generation behavioral healthcare.

Threat:

Competition from established therapies

The novelty, of VR therapy must contend with entrenched treatment modalities like pharmacotherapy, cognitive behavioral therapy (CBT), and EMDR (Eye Movement Desensitization and Reprocessing). These approaches have decades of clinical validation and widespread practitioner familiarity, making them the default choice for many providers. Moreover, reimbursement frameworks and clinical guidelines often favor conventional therapies, limiting VR's market penetration. Skepticism among clinicians regarding long-term efficacy and cost-effectiveness of VR solutions may further slow adoption.

Covid-19 Impact:

The pandemic accelerated interest in remote and digital mental health solutions, including VR-based PTSD therapy. Lockdowns and social distancing measures disrupted in-person counseling, prompting providers to explore immersive technologies for continuity of care. VR platforms enabled patients to undergo exposure therapy from home, reducing barriers to access and enhancing treatment adherence. However, supply chain disruptions affected hardware availability, and economic uncertainty limited institutional investments in new technologies.

The cognitive behavioral therapy segment is expected to be the largest during the forecast period

The cognitive behavioral therapy segment is expected to account for the largest market share during the forecast period due to its structured, evidence-based approach that aligns well with VR delivery. CBT modules can be effectively translated into immersive scenarios, allowing patients to confront and reframe traumatic memories in a controlled environment. The adaptability of CBT to various trauma types and its compatibility with digital platforms make it a preferred choice among clinicians.

The post-traumatic stress disorder (PTSD) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the post-traumatic stress disorder (PTSD) segment is predicted to witness the highest growth rate driven by increasing awareness and diagnosis of trauma-related conditions. Rising incidences of PTSD among civilians, first responders, and healthcare workers are expanding the target population. VR therapy offers a non-invasive, stigma-free alternative to traditional counseling, making it particularly appealing for younger demographics. Continued research into trauma-specific VR modules and growing institutional support for mental health initiatives are fueling market expansion.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share propelled by rising mental health awareness and expanding access to digital healthcare infrastructure. Countries like China, Japan, and South Korea are investing heavily in VR technologies and integrating them into public health systems. Government-backed initiatives promoting mental wellness and trauma recovery are creating favorable conditions for market growth.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR attributed to robust healthcare infrastructure, early adoption of emerging technologies, and strong presence of VR therapy startups. The region benefits from favorable reimbursement policies, active research funding, and a high prevalence of PTSD cases, particularly among veterans. Collaborations between tech companies and academic institutions are accelerating innovation, while regulatory bodies are increasingly recognizing VR as a legitimate therapeutic tool.

Key players in the market

Some of the key players in PTSD VR Therapy Market include XRHealth, AppliedVR, Limbix, Psious, MyndVR, KindVR, Corpus VR, Cognihab, RelieVRx, Virtually Better, Neuro Rehab VR, PsyTech VR, oVRcome, Floreo, BehaVR, Oxford VR, and Enosis Therapeutics.

Key Developments:

In July 2025, PsyTech VR published a v2.0.7 product update announcing enhanced AI tools and also showcased at ACBS World Conference. The June update described incremental product improvements to treatment protocols and clinician tooling; conference presence (July) promoted clinical adoption.

In June 2025, Floreo announced the launch of a Scientific Advisory Board to advance evidence-based VR therapy for neurodivergent learners. Additionally, Floreo was selected by Center for Social Dynamics to expand VR ABA services in U.S. schools

In April 2025, Mynd Immersive announced an expansion delivering VR therapeutics to >150 U.S. senior-living communities. The release highlights partnerships (e.g., Select Rehabilitation, HTC VIVE, AT&T) to scale immersive therapeutics across senior care and post-acute settings.

Types Covered:

  • Exposure Therapy
  • Cognitive Behavioral Therapy
  • Eye Movement Desensitization and Reprocessing
  • Biofeedback-augmented VR therapy
  • Combined / Hybrid Therapy Models
  • Other Types

Components Covered:

  • Hardware
  • Software
  • Services
  • Other Components

Modalities Covered:

  • Immersive VR
  • Semi-Immersive
  • Non-Immersive

Applications Covered:

  • Depression
  • Anxiety Disorders
  • Post-Traumatic Stress Disorder (PTSD)
  • Pain Management
  • Addiction Management
  • Other Applications

End Users Covered:

  • Therapy Clinics & Rehabilitation Centers
  • Military & Defense
  • Hospitals & Clinics
  • Research & Academic Institutions
  • Homecare Settings
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global PTSD VR Therapy Market, By Type

  • 5.1 Introduction
  • 5.2 Exposure Therapy
  • 5.3 Cognitive Behavioral Therapy
  • 5.4 Eye Movement Desensitization and Reprocessing
  • 5.5 Biofeedback-augmented VR therapy
  • 5.6 Combined / Hybrid Therapy Models
  • 5.7 Other Types

6 Global PTSD VR Therapy Market, By Component

  • 6.1 Introduction
  • 6.2 Hardware
    • 6.2.1 Head-Mounted Displays (HMDs)
    • 6.2.2 Controllers & Tracking Systems
    • 6.2.3 Physiological Sensors
    • 6.2.4 Haptics & peripherals
  • 6.3 Software
    • 6.3.1 Simulation Content & Scenario Libraries
    • 6.3.2 Clinical Management & Analytics Software
  • 6.4 Services
    • 6.4.1 Software Customization & Integration Services
    • 6.4.2 Clinical Implementation & Therapist Training
    • 6.4.3 Maintenance & Support
  • 6.5 Other Components

7 Global PTSD VR Therapy Market, By Modality

  • 7.1 Introduction
  • 7.2 Immersive VR
  • 7.3 Semi-Immersive
  • 7.4 Non-Immersive

8 Global PTSD VR Therapy Market, By Application

  • 8.1 Introduction
  • 8.2 Depression
  • 8.3 Anxiety Disorders
  • 8.4 Post-Traumatic Stress Disorder (PTSD)
  • 8.5 Pain Management
  • 8.6 Addiction Management
  • 8.7 Other Applications

9 Global PTSD VR Therapy Market, By End User

  • 9.1 Introduction
  • 9.2 Therapy Clinics & Rehabilitation Centers
  • 9.3 Military & Defense
  • 9.4 Hospitals & Clinics
  • 9.5 Research & Academic Institutions
  • 9.6 Homecare Settings
  • 9.7 Other End Users

10 Global PTSD VR Therapy Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 XRHealth
  • 12.2 AppliedVR
  • 12.3 Limbix
  • 12.4 Psious
  • 12.5 MyndVR
  • 12.6 KindVR
  • 12.7 Corpus VR
  • 12.8 Cognihab
  • 12.9 RelieVRx
  • 12.10 Virtually Better
  • 12.11 Neuro Rehab VR
  • 12.12 PsyTech VR
  • 12.13 oVRcome
  • 12.14 Floreo
  • 12.15 BehaVR
  • 12.16 Oxford VR
  • 12.17 Enosis Therapeutics

List of Tables

  • Table 1 Global PTSD VR Therapy Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global PTSD VR Therapy Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global PTSD VR Therapy Market Outlook, By Exposure Therapy (2024-2032) ($MN)
  • Table 4 Global PTSD VR Therapy Market Outlook, By Cognitive Behavioral Therapy (2024-2032) ($MN)
  • Table 5 Global PTSD VR Therapy Market Outlook, By Eye Movement Desensitization and Reprocessing (2024-2032) ($MN)
  • Table 6 Global PTSD VR Therapy Market Outlook, By Biofeedback-augmented VR therapy (2024-2032) ($MN)
  • Table 7 Global PTSD VR Therapy Market Outlook, By Combined / Hybrid Therapy Models (2024-2032) ($MN)
  • Table 8 Global PTSD VR Therapy Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 9 Global PTSD VR Therapy Market Outlook, By Component (2024-2032) ($MN)
  • Table 10 Global PTSD VR Therapy Market Outlook, By Hardware (2024-2032) ($MN)
  • Table 11 Global PTSD VR Therapy Market Outlook, By Head-Mounted Displays (HMDs) (2024-2032) ($MN)
  • Table 12 Global PTSD VR Therapy Market Outlook, By Controllers & Tracking Systems (2024-2032) ($MN)
  • Table 13 Global PTSD VR Therapy Market Outlook, By Physiological Sensors (2024-2032) ($MN)
  • Table 14 Global PTSD VR Therapy Market Outlook, By Haptics & peripherals (2024-2032) ($MN)
  • Table 15 Global PTSD VR Therapy Market Outlook, By Software (2024-2032) ($MN)
  • Table 16 Global PTSD VR Therapy Market Outlook, By Simulation Content & Scenario Libraries (2024-2032) ($MN)
  • Table 17 Global PTSD VR Therapy Market Outlook, By Clinical Management & Analytics Software (2024-2032) ($MN)
  • Table 18 Global PTSD VR Therapy Market Outlook, By Services (2024-2032) ($MN)
  • Table 19 Global PTSD VR Therapy Market Outlook, By Software Customization & Integration Services (2024-2032) ($MN)
  • Table 20 Global PTSD VR Therapy Market Outlook, By Clinical Implementation & Therapist Training (2024-2032) ($MN)
  • Table 21 Global PTSD VR Therapy Market Outlook, By Maintenance & Support (2024-2032) ($MN)
  • Table 22 Global PTSD VR Therapy Market Outlook, By Other Components (2024-2032) ($MN)
  • Table 23 Global PTSD VR Therapy Market Outlook, By Modality (2024-2032) ($MN)
  • Table 24 Global PTSD VR Therapy Market Outlook, By Immersive VR (2024-2032) ($MN)
  • Table 25 Global PTSD VR Therapy Market Outlook, By Semi-Immersive (2024-2032) ($MN)
  • Table 26 Global PTSD VR Therapy Market Outlook, By Non-Immersive (2024-2032) ($MN)
  • Table 27 Global PTSD VR Therapy Market Outlook, By Application (2024-2032) ($MN)
  • Table 28 Global PTSD VR Therapy Market Outlook, By Depression (2024-2032) ($MN)
  • Table 29 Global PTSD VR Therapy Market Outlook, By Anxiety Disorders (2024-2032) ($MN)
  • Table 30 Global PTSD VR Therapy Market Outlook, By Post-Traumatic Stress Disorder (PTSD) (2024-2032) ($MN)
  • Table 31 Global PTSD VR Therapy Market Outlook, By Pain Management (2024-2032) ($MN)
  • Table 32 Global PTSD VR Therapy Market Outlook, By Addiction Management (2024-2032) ($MN)
  • Table 33 Global PTSD VR Therapy Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 34 Global PTSD VR Therapy Market Outlook, By End User (2024-2032) ($MN)
  • Table 35 Global PTSD VR Therapy Market Outlook, By Therapy Clinics & Rehabilitation Centers (2024-2032) ($MN)
  • Table 36 Global PTSD VR Therapy Market Outlook, By Military & Defense (2024-2032) ($MN)
  • Table 37 Global PTSD VR Therapy Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 38 Global PTSD VR Therapy Market Outlook, By Research & Academic Institutions (2024-2032) ($MN)
  • Table 39 Global PTSD VR Therapy Market Outlook, By Homecare Settings (2024-2032) ($MN)
  • Table 40 Global PTSD VR Therapy Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.